The S&P 500 fell 2.68% this week but the average stock did much better. $APP rose 71.20% with a high 90.6 Dad Score. High-quality $VCYT plunged 51.69% despite its 95.6 Dad Score. The big index numbers lied.
#stocks #investing
#stocks #investing
November 7, 2026 at 11:56 PM
The S&P 500 fell 2.68% this week but the average stock did much better. $APP rose 71.20% with a high 90.6 Dad Score. High-quality $VCYT plunged 51.69% despite its 95.6 Dad Score. The big index numbers lied.
#stocks #investing
#stocks #investing
SELL $VCYT (VCYT.O) [GuidanceChange] @ 22:10:51Z
November 4, 2026 at 10:10 PM
SELL $VCYT (VCYT.O) [GuidanceChange] @ 22:10:51Z
$VCYT fell 54.30% as a narrower outlook overshadowed an earnings beat. $MNTN dropped 54.68% on a 35.48% EPS miss. $ELPW lost 48.01% despite a new $300 million deal. $DDD fell 36.74% and $PCT lost 32.62% after earnings.
#stocks #investing
#stocks #investing
November 6, 2026 at 3:00 AM
$VCYT fell 54.30% as a narrower outlook overshadowed an earnings beat. $MNTN dropped 54.68% on a 35.48% EPS miss. $ELPW lost 48.01% despite a new $300 million deal. $DDD fell 36.74% and $PCT lost 32.62% after earnings.
#stocks #investing
#stocks #investing
#VCYT Veracyte Announces Third Quarter 2026 Financial Results
https://www.stocktitan.net/news/VCYT/veracyte-announces-third-quarter-2026-financial-8vwzorj4ukxn.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VCYT/veracyte-announces-third-quarter-2026-financial-8vwzorj4ukxn.html?utm_source=stocktitan-bluesky&utm_medium=social
Veracyte Announces Third Quarter 2026 Financial Results
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 4, 2026 at 9:05 PM
#VCYT Veracyte Announces Third Quarter 2026 Financial Results
https://www.stocktitan.net/news/VCYT/veracyte-announces-third-quarter-2026-financial-8vwzorj4ukxn.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VCYT/veracyte-announces-third-quarter-2026-financial-8vwzorj4ukxn.html?utm_source=stocktitan-bluesky&utm_medium=social
#$RVMD -7%: New pancreatic drug hit $198M in 5 wks but sales may slow + high spending. #$VCYT -56%: Rev +15% but key test volumes missed; growth cut. #$ARQT -23%: Zoryve +45%, guidance up, profits missed on higher costs. #$EWTX: FDA OK for HCM drug; Phase 3 starts Q4 2026. notreload.xyz/wall-street-...
November 5, 2026 at 5:52 PM
#$RVMD -7%: New pancreatic drug hit $198M in 5 wks but sales may slow + high spending. #$VCYT -56%: Rev +15% but key test volumes missed; growth cut. #$ARQT -23%: Zoryve +45%, guidance up, profits missed on higher costs. #$EWTX: FDA OK for HCM drug; Phase 3 starts Q4 2026. notreload.xyz/wall-street-...
🚨 $VCYT
On November 4, 2026, Veracyte, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report.
On November 4, 2026, Veracyte, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report.
SEC Filing: VCYT
Click to view the official SEC document.
www.sec.gov
November 4, 2026 at 9:20 PM
🚨 $VCYT
On November 4, 2026, Veracyte, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report.
On November 4, 2026, Veracyte, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report.
Investigation Launched Into Veracyte as Shareholders Face Major Losses#USA#New_York#Levi_&_Korsinsky#Veracyte#VCYT
Investigation Launched Into Veracyte as Shareholders Face Major Losses
Levi & Korsinsky announces an investigation into Veracyte due to significant shareholder losses after disappointing test volume results.
third-news.com
November 6, 2026 at 12:52 AM
Investigation Launched Into Veracyte as Shareholders Face Major Losses#USA#New_York#Levi_&_Korsinsky#Veracyte#VCYT
📊 MARKET PULSE — Thu, Nov 5 · 10:01 AM ET
SPY $754.19
QQQ $666.62
DIA $529.38
VIX 20.50
10Y 4.95%
Gold $4,118.40
Silver $52.26
GSR 78.8
Brent $96.92
BTC $78,011
ETH $2,335
🏆 AMTX +45.2% | 💀 VCYT -54.9%
#Markets #TickerTap
SPY $754.19
QQQ $666.62
DIA $529.38
VIX 20.50
10Y 4.95%
Gold $4,118.40
Silver $52.26
GSR 78.8
Brent $96.92
BTC $78,011
ETH $2,335
🏆 AMTX +45.2% | 💀 VCYT -54.9%
#Markets #TickerTap
November 5, 2026 at 3:01 PM
📊 MARKET PULSE — Thu, Nov 5 · 10:01 AM ET
SPY $754.19
QQQ $666.62
DIA $529.38
VIX 20.50
10Y 4.95%
Gold $4,118.40
Silver $52.26
GSR 78.8
Brent $96.92
BTC $78,011
ETH $2,335
🏆 AMTX +45.2% | 💀 VCYT -54.9%
#Markets #TickerTap
SPY $754.19
QQQ $666.62
DIA $529.38
VIX 20.50
10Y 4.95%
Gold $4,118.40
Silver $52.26
GSR 78.8
Brent $96.92
BTC $78,011
ETH $2,335
🏆 AMTX +45.2% | 💀 VCYT -54.9%
#Markets #TickerTap
📊 Today's biggest movers:
📈 $AEHL +96.2% — extending massive low-float momentum!
📉 $VCYT -53.8%
📈 $LYNX +53.5% — blowout earnings debut and major analyst…
📉 $MNTN -49.8%
Full movers board → https://premarketprice.com/premarket-movers?utm_source=bluesky&utm_medium=social&utm_campaign=movers
📈 $AEHL +96.2% — extending massive low-float momentum!
📉 $VCYT -53.8%
📈 $LYNX +53.5% — blowout earnings debut and major analyst…
📉 $MNTN -49.8%
Full movers board → https://premarketprice.com/premarket-movers?utm_source=bluesky&utm_medium=social&utm_campaign=movers
Today's Biggest Movers | PreMarketPrice
Live movers board — abnormal moves with catalysts and fundamental context.
premarketprice.com
November 6, 2026 at 9:05 PM
📊 Today's biggest movers:
📈 $AEHL +96.2% — extending massive low-float momentum!
📉 $VCYT -53.8%
📈 $LYNX +53.5% — blowout earnings debut and major analyst…
📉 $MNTN -49.8%
Full movers board → https://premarketprice.com/premarket-movers?utm_source=bluesky&utm_medium=social&utm_campaign=movers
📈 $AEHL +96.2% — extending massive low-float momentum!
📉 $VCYT -53.8%
📈 $LYNX +53.5% — blowout earnings debut and major analyst…
📉 $MNTN -49.8%
Full movers board → https://premarketprice.com/premarket-movers?utm_source=bluesky&utm_medium=social&utm_campaign=movers
$KPTI to be delisted from Nasdaq after Ch.11 filing; trading halted Nov 11. Shares move to OTC as KPTIQ, high risk of share cancellation. $AKBA $ANVS $IRWD $VCYT $PBYI $MYGN $ARAY $CAI
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Pre-Market Updates 11/05/26
export-download.canva.com
November 5, 2026 at 1:40 PM
$KPTI to be delisted from Nasdaq after Ch.11 filing; trading halted Nov 11. Shares move to OTC as KPTIQ, high risk of share cancellation. $AKBA $ANVS $IRWD $VCYT $PBYI $MYGN $ARAY $CAI
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Early👀11-5-26
Spu+2, Naz-240, DJI+265
10-yr 4.89%, 2-yr 4.61%
Crude+1.6%, Gold+1.4%, Slv+.5%
BTC-.75%
CHANGES
UP: AFYA, CNK, EW, FSLR, GTM, JBLU,
JOBY, LYNX, MTRN, PCOR, TREX, ULCC,
DN: AARD, ARM, BCC, CSCO, DLTR, FIS,
HUBS, LZ, MNTN, NKE, PAGS, PAYC, SFM,
SLF, STNE, SWKS, UNP, VCYT, XPRO
Spu+2, Naz-240, DJI+265
10-yr 4.89%, 2-yr 4.61%
Crude+1.6%, Gold+1.4%, Slv+.5%
BTC-.75%
CHANGES
UP: AFYA, CNK, EW, FSLR, GTM, JBLU,
JOBY, LYNX, MTRN, PCOR, TREX, ULCC,
DN: AARD, ARM, BCC, CSCO, DLTR, FIS,
HUBS, LZ, MNTN, NKE, PAGS, PAYC, SFM,
SLF, STNE, SWKS, UNP, VCYT, XPRO
November 5, 2026 at 12:57 PM
Early👀11-5-26
Spu+2, Naz-240, DJI+265
10-yr 4.89%, 2-yr 4.61%
Crude+1.6%, Gold+1.4%, Slv+.5%
BTC-.75%
CHANGES
UP: AFYA, CNK, EW, FSLR, GTM, JBLU,
JOBY, LYNX, MTRN, PCOR, TREX, ULCC,
DN: AARD, ARM, BCC, CSCO, DLTR, FIS,
HUBS, LZ, MNTN, NKE, PAGS, PAYC, SFM,
SLF, STNE, SWKS, UNP, VCYT, XPRO
Spu+2, Naz-240, DJI+265
10-yr 4.89%, 2-yr 4.61%
Crude+1.6%, Gold+1.4%, Slv+.5%
BTC-.75%
CHANGES
UP: AFYA, CNK, EW, FSLR, GTM, JBLU,
JOBY, LYNX, MTRN, PCOR, TREX, ULCC,
DN: AARD, ARM, BCC, CSCO, DLTR, FIS,
HUBS, LZ, MNTN, NKE, PAGS, PAYC, SFM,
SLF, STNE, SWKS, UNP, VCYT, XPRO
🚨 $VCYT
Wygant Jonathan (VP, Chief Accounting Officer) reported special transactions (Non-P/S).
Wygant Jonathan (VP, Chief Accounting Officer) reported special transactions (Non-P/S).
SEC Filing: VCYT
Click to view the official SEC document.
www.sec.gov
October 29, 2026 at 8:51 PM
🚨 $VCYT
Wygant Jonathan (VP, Chief Accounting Officer) reported special transactions (Non-P/S).
Wygant Jonathan (VP, Chief Accounting Officer) reported special transactions (Non-P/S).
🚨 $VCYT
Holstein Jens (Insider) sold 15,000 shares at an average price of $48.5000 per common share. (Date: 2026-10-27)
Holstein Jens (Insider) sold 15,000 shares at an average price of $48.5000 per common share. (Date: 2026-10-27)
SEC Filing: VCYT
Click to view the official SEC document.
www.sec.gov
October 28, 2026 at 8:07 PM
🚨 $VCYT
Holstein Jens (Insider) sold 15,000 shares at an average price of $48.5000 per common share. (Date: 2026-10-27)
Holstein Jens (Insider) sold 15,000 shares at an average price of $48.5000 per common share. (Date: 2026-10-27)
🚨 $VCYT
EASTHAM KARIN (Insider) sold 14,850 shares at an average price of $50.0049 per common share. (Date: 2026-10-27)
EASTHAM KARIN (Insider) sold 14,850 shares at an average price of $50.0049 per common share. (Date: 2026-10-27)
SEC Filing: VCYT
Click to view the official SEC document.
www.sec.gov
October 28, 2026 at 8:07 PM
🚨 $VCYT
EASTHAM KARIN (Insider) sold 14,850 shares at an average price of $50.0049 per common share. (Date: 2026-10-27)
EASTHAM KARIN (Insider) sold 14,850 shares at an average price of $50.0049 per common share. (Date: 2026-10-27)
🚨 $VCYT
KARIN EASTHAM, a Director, filed a notice of intent to sell 14,850 shares of common stock, valued at approximately $715,770.00, on 10/27/2026.
KARIN EASTHAM, a Director, filed a notice of intent to sell 14,850 shares of common stock, valued at approximately $715,770.00, on 10/27/2026.
SEC Filing: VCYT
Click to view the official SEC document.
www.sec.gov
October 27, 2026 at 8:34 PM
🚨 $VCYT
KARIN EASTHAM, a Director, filed a notice of intent to sell 14,850 shares of common stock, valued at approximately $715,770.00, on 10/27/2026.
KARIN EASTHAM, a Director, filed a notice of intent to sell 14,850 shares of common stock, valued at approximately $715,770.00, on 10/27/2026.
🚨 $VCYT
JENS HOLSTEIN, a Director, filed a notice of intent to sell 7,500 shares of common stock, valued at approximately $375,000.00, on 10/27/2026.
JENS HOLSTEIN, a Director, filed a notice of intent to sell 7,500 shares of common stock, valued at approximately $375,000.00, on 10/27/2026.
SEC Filing: VCYT
Click to view the official SEC document.
www.sec.gov
October 27, 2026 at 8:09 PM
🚨 $VCYT
JENS HOLSTEIN, a Director, filed a notice of intent to sell 7,500 shares of common stock, valued at approximately $375,000.00, on 10/27/2026.
JENS HOLSTEIN, a Director, filed a notice of intent to sell 7,500 shares of common stock, valued at approximately $375,000.00, on 10/27/2026.
$IR-1 $QQQM-1 $TEM-1 $MU-1 $ASML-1 $AXP-1 $CMPS-1 $SMCI-1 $DELL-1 $ON-1 $JBLU-1 $PUMP-1 $LITE-1 $LFUS-1 $VOO-1 $VCYT-1 $IE-1 $OKLO-1 $DASH-1 $ALLE-1 $BAX-1 $PLTR-1 $CVS-1
Daily Wrap - Final Message: Daily Wrap up for 2026-10-27 - 601 events.
#burst_trades #HFT #trading ...
Daily Wrap - Final Message: Daily Wrap up for 2026-10-27 - 601 events.
#burst_trades #HFT #trading ...
October 27, 2026 at 8:37 PM
$IR-1 $QQQM-1 $TEM-1 $MU-1 $ASML-1 $AXP-1 $CMPS-1 $SMCI-1 $DELL-1 $ON-1 $JBLU-1 $PUMP-1 $LITE-1 $LFUS-1 $VOO-1 $VCYT-1 $IE-1 $OKLO-1 $DASH-1 $ALLE-1 $BAX-1 $PLTR-1 $CVS-1
Daily Wrap - Final Message: Daily Wrap up for 2026-10-27 - 601 events.
#burst_trades #HFT #trading ...
Daily Wrap - Final Message: Daily Wrap up for 2026-10-27 - 601 events.
#burst_trades #HFT #trading ...
🚨 $VCYT
Bhanji Muna (Insider) sold 1,864 shares at an average price of $43.7000 per common share. (Date: 2026-10-19)
Bhanji Muna (Insider) sold 1,864 shares at an average price of $43.7000 per common share. (Date: 2026-10-19)
SEC Filing: VCYT
Click to view the official SEC document.
www.sec.gov
October 20, 2026 at 8:12 PM
🚨 $VCYT
Bhanji Muna (Insider) sold 1,864 shares at an average price of $43.7000 per common share. (Date: 2026-10-19)
Bhanji Muna (Insider) sold 1,864 shares at an average price of $43.7000 per common share. (Date: 2026-10-19)
#VCYT Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
https://www.stocktitan.net/news/VCYT/six-studies-to-highlight-veracyte-s-genomic-tests-across-breast-u6wrvxncedgw.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VCYT/six-studies-to-highlight-veracyte-s-genomic-tests-across-breast-u6wrvxncedgw.html?utm_source=stocktitan-bluesky&utm_medium=social
Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
Veracyte (Nasdaq: VCYT) announced six studies involving its genomic tests will be presented at ESMO 2026, October 23–27 in Madrid.The presentations cover prostate and bladder cancer treatment selection and risk assessment, plus breast cancer health economics. Veracyte said a Decipher Prostate oral presentation will provide the first evidence that the test predicts benefit from adding abiraterone to androgen deprivation therapy for clinically very high-risk, nonmetastatic prostate cancer. A separate late-breaking oral presentation will report a two-year, within-trial economic analysis of Prosigna-guided chemotherapy decisions in the Phase III OPTIMA breast cancer trial. Four posters address additional prostate and bladder cancer research.
www.stocktitan.net
October 19, 2026 at 12:00 PM
#VCYT Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
https://www.stocktitan.net/news/VCYT/six-studies-to-highlight-veracyte-s-genomic-tests-across-breast-u6wrvxncedgw.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VCYT/six-studies-to-highlight-veracyte-s-genomic-tests-across-breast-u6wrvxncedgw.html?utm_source=stocktitan-bluesky&utm_medium=social
ARK rebalance 10/6: the air-taxi spree — #$ACHR bought in 3 funds (ARKK/ARKQ/ARKX), #$JOBY in 2, #$AUR. Space rotates: #$AVAV + #$LUNR in, #$IRDM out. #$HOOD trimmed ×2, #$SPCX sold in ARKW. Genomics shuffle: $VCYT/$RXRX/$NTLA in, $TXG/$TWST/$PSNL out. #$TER sold ×2 as chip equipment bled.
October 7, 2026 at 12:33 AM
🚀 ARK rebalance 10/5: BUY #$RXRX #$NTLA #$VCYT #$FRNM #$SCTX 🧬 SELL #$TWST #$TXG #$CDNA ✂️ Money rotates toward AI drug discovery, gene editing & early cancer detection, away from tools and legacy diagnostics. Small trims, big signal 👀 Slow, staged accumulation wins. Not advice, just watching the flow.
October 6, 2026 at 12:21 AM
🚀 ARK rebalance 10/5: BUY #$RXRX #$NTLA #$VCYT #$FRNM #$SCTX 🧬 SELL #$TWST #$TXG #$CDNA ✂️ Money rotates toward AI drug discovery, gene editing & early cancer detection, away from tools and legacy diagnostics. Small trims, big signal 👀 Slow, staged accumulation wins. Not advice, just watching the flow.
🚀 Cathie's 10/1 list: #$RKLB in THREE ARK funds (235K shares) — biggest Electron deal + Citi Buy at $105 🛰️ #$NTLA ×2 funds, #$VCYT 🧬 #$BWXT nuclear ⚛️ Funded by trimming #$PLTR 💸 Rockets, reactors, CRISPR — the AI darling gets a haircut ✂️ [NOT FINANCIAL ADVICE, DYOR!] from Humble Trader | Gemini Trading
October 2, 2026 at 12:14 AM
🚀 Cathie's 10/1 list: #$RKLB in THREE ARK funds (235K shares) — biggest Electron deal + Citi Buy at $105 🛰️ #$NTLA ×2 funds, #$VCYT 🧬 #$BWXT nuclear ⚛️ Funded by trimming #$PLTR 💸 Rockets, reactors, CRISPR — the AI darling gets a haircut ✂️ [NOT FINANCIAL ADVICE, DYOR!] from Humble Trader | Gemini Trading
🧬 ARK's 9/30 rebalance: gene editing IN, megacap trims OUT. @CathieDWood @ARKInvest added #$NTLA (ARKK/ARKG) and #$VCYT, while nibbling #$GOOGL and #$Z. Tiny trims, bigger biotech conviction. Not a tech exit, a rotation toward the next S-curve. 📈 Watch the double-fund buys — that's the signal.
October 1, 2026 at 12:17 AM
#VCYT Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
https://www.stocktitan.net/news/VCYT/phase-iii-trial-demonstrates-veracyte-s-decipher-prostate-test-7lwur4nl7ddo.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VCYT/phase-iii-trial-demonstrates-veracyte-s-decipher-prostate-test-7lwur4nl7ddo.html?utm_source=stocktitan-bluesky&utm_medium=social
Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 29, 2026 at 12:00 PM
#VCYT Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
https://www.stocktitan.net/news/VCYT/phase-iii-trial-demonstrates-veracyte-s-decipher-prostate-test-7lwur4nl7ddo.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VCYT/phase-iii-trial-demonstrates-veracyte-s-decipher-prostate-test-7lwur4nl7ddo.html?utm_source=stocktitan-bluesky&utm_medium=social
Final Tally - 581/301/268/12 ... OTEs are ...
Daily Wrap - Tickers: $QQQ-169 $SPY-39 $IWM-37 $TQQQ-30 $NVDA-17 $VOO-10 $SOXS-9 $SOXL-8 $INTC-8 $SPCX-8 $DRAM-6 $DIA-5 $AAPL-5 $TNA-5 $QLD-5 $XLK-5 $IVV-4 $NVDL-4 $AMZN-3 $NVTS-3 $LOFF-3 $VCYT-3
Daily Wrap - Tickers: $QQQ-169 $SPY-39 $IWM-37 $TQQQ-30 $NVDA-17 $VOO-10 $SOXS-9 $SOXL-8 $INTC-8 $SPCX-8 $DRAM-6 $DIA-5 $AAPL-5 $TNA-5 $QLD-5 $XLK-5 $IVV-4 $NVDL-4 $AMZN-3 $NVTS-3 $LOFF-3 $VCYT-3
September 29, 2026 at 8:13 PM
Final Tally - 581/301/268/12 ... OTEs are ...
Daily Wrap - Tickers: $QQQ-169 $SPY-39 $IWM-37 $TQQQ-30 $NVDA-17 $VOO-10 $SOXS-9 $SOXL-8 $INTC-8 $SPCX-8 $DRAM-6 $DIA-5 $AAPL-5 $TNA-5 $QLD-5 $XLK-5 $IVV-4 $NVDL-4 $AMZN-3 $NVTS-3 $LOFF-3 $VCYT-3
Daily Wrap - Tickers: $QQQ-169 $SPY-39 $IWM-37 $TQQQ-30 $NVDA-17 $VOO-10 $SOXS-9 $SOXL-8 $INTC-8 $SPCX-8 $DRAM-6 $DIA-5 $AAPL-5 $TNA-5 $QLD-5 $XLK-5 $IVV-4 $NVDL-4 $AMZN-3 $NVTS-3 $LOFF-3 $VCYT-3